Nephrocare Health Services cash flow

Latest FY26

Cash from operations: ₹233cr
Capital spending: ₹119cr
Free cash flow: ₹113cr
Cash from financing: ₹157cr

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Adjustments to reconcile profit — non-cash items
	90.7
	60.2
	−9.5
	9.2
	14.5
Changes in working capital
	−5.5
	−68.8
	−0.8
	−13.0
	32.8
	46.6
	0.9
	2.1
Cash from operating activities
	101
	159
	260
	27.5
	233
Cash from investing activities
	119
	0.4
	0.2
	50.4
	4.2
	0.5
	8.0
	−245
	−410
Cash from financing activities
	390
	203
	11.8
	18.5
	157
	−20.7
	18.8
	−1.9
Reference items
	227
	22.7%
	113
	₹11.28
	3.03×
	27.5
	18.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEPHROPLUS₹628.55

Nephrocare Health Services Limited

· Pharma & Health

₹ CrorePeersKRSNAA SURAKSHA HEALTHX 3BBLACKBIOMcap ₹6,307 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026
	Adjustments to Reconcile Profit — Non-cash Items
	+ Depreciation & Amortisation	90.7
	+ Finance Costs	60.2
	+ Interest Income	-9.5
	+ Share-based Payments	9.2
	+ Other Non-cash Items	14.5
	Changes in Working Capital
	+ Inventories	-5.5
	+ Trade Receivables — Current	-68.8
	+ Other Financial Assets — Current	-0.8
	+ Other Current Assets	-13.0
	+ Trade Payables — Current	32.8
	+ Other Financial Liabilities — Current	46.6
	+ Other Current Liabilities	0.9
	+ Provisions — Current	2.1
	Cash from Operating Activities
	Profit Before Tax (per I/S)	100.6
	+ Total Adjustments (incl. Working Capital)	159.5
	Cash from Operations (pre-tax)	260.1
	+ Income Taxes Paid	27.5
	Cash from Operating Activities	232.6
	Cash from Investing Activities
	+ Acq of Fixed Assets (Capex)	118.9
	+ Acq of Intangible Assets	0.4
	+ Disp of Fixed Assets	0.2
	+ Purchase of Investments (Equity / Debt)	50.4
	+ Acq of Interests in Joint Ventures	4.2
	+ Disp of Subsidiaries / Businesses (net)	0.5
	+ Interest Received — Investing	8.0
	+ Other Inflows / (Outflows) — Investing	-245.3
	Cash from Investing Activities	-410.4
	Cash from Financing Activities
	+ Proceeds from Issue of Shares	390.2
	+ Repayment of Borrowings	202.8
	+ Payment of Lease Liabilities	11.8
	+ Interest Paid	18.5
	Cash from Financing Activities	157.1
	Net Changes in Cash (pre-FX)	-20.7
	+ Effect of FX Rate Changes on Cash	18.8
	Net Changes in Cash	-1.9
	Reference Items
	EBITDA	227.0
	EBITDA Margin %	22.72
	Free Cash Flow (CFO − Capex)	113.2
	Free Cash Flow per Basic Share	11.28
	Cash Flow to Net Income	3.03
	Cash Paid for Taxes	27.5
	Cash Paid for Interest	18.5

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.